A new biotech company plans to make lower-cost branded drugs. Two of President Trump's healthcare initiatives are back in court. And retiring CEO of St. Luke's Health System Dr. David Pate says the way to reign in healthcare spending is to get rid of low-value care.
Hosted on Acast. See acast.com/privacy for more information.
